More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project.
The researchers from Monash University, RMIT University, The University of Melbourne and the Baker Institute developed the system to respond to glucose, which current insulin does not.
Co-first author Dr. Rong Xu, from the Monash University Central Clinical School’s Australian Center for Blood Diseases, and Dr. Sukhvir Kaur Bhangu from RMIT University and the University of Melbourne said if it worked in humans, only two injections would be needed per day.
Current insulin therapy requires people to monitor their blood sugar throughout the day and take multiple, carefully calculated doses based on food intake, exercise, stress, illness and other factors.
Some must inject themselves up to five times a day. Continuous glucose monitoring devices remove, or at least reduce, the need for finger pricks, and insulin pumps can automatically deliver insulin, but they are very expensive and still are not always able to calculate the correct amount of insulin to be given.
The multidisciplinary team developed a new “artificial pancreas system” using phytoglycogen nanoparticles, which are chains on glucose molecules dubbed a “nanosugar platform” as they are made of glucose, to deliver and release insulin in response to glucose levels in the blood.
This engineered nanosugar platform enabled rapid and sustained glucose-responsive insulin delivery, which was longer lasting and smarter than other systems.
Dr. Xu said it required only one injection every 12 hours and self-regulated. “This system would mean fewer injections and, potentially, no need to measure glucose,” Dr. Xu said.
The research emerged from an NHMRC Ideas Grant awarded to co-lead author and Head of Monash University’s Australian Center for Blood Diseases NanoBiotechnology Laboratory, Professor Christoph Hagemeyer, co-lead author and RMIT Associate Professor Francesca Cavalieri, and co-author Professor Frank Caruso at the University of Melbourne to develop this revolutionary type of insulin.
Professor Hagemeyer said more research was needed but the results were promising. He said the nanosugar platform was biodegradable, which enabled rapid and extended glucose control in two different models of type 1 diabetes with a single injection.
“The nanosugar particles are engineered to control insulin release and absorption through the lymphatic system into the blood,” he said.
Professor Cavalieri said the research team, which includes several clinicians, now hoped to secure funding to continue the project and eventually undertake clinical trials. “This new method is not only efficient, it’s biodegradable and uses natural methods, which significantly reduces the chances of adverse affects or immune reactions,” she said.
News
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
